Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |